UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 18, 2018 5:00 P.M.
Form:
S-3
CIK:
0000887247
Company Name:
Adamis Pharmaceuticals Corp
File Number:
333-226100